Cargando…

Clinical Outcomes of Immunocompromised Adults Hospitalized with Pneumococcal Pneumonia: A Case-Control Study

S. pneumoniae is a primary etiologic agent of CAP in immunocompromised adults (ICA). Data on clinical outcomes of ICA hospitalized with pneumococcal pneumonia (PP) is limited. The objectives of this study were (1) to define clinical presentation and outcomes of ICA hospitalized with PP and (2) to co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramirez, Julio, Chandler, Thomas, Furmanek, Stephen, Arnold, Forest, Bordon, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399246/ https://www.ncbi.nlm.nih.gov/pubmed/34442825 http://dx.doi.org/10.3390/microorganisms9081746

Ejemplares similares

2110. Immunocompromised Adults Hospitalized with Community-Acquired Pneumonia in the United States: Incidence and Clinical Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2022)

Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2023)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae
por: Chandler, Thomas, et al.
Publicado: (2022)

Epidemiology of Pneumococcal Pneumonia in Louisville, Kentucky, and Its Estimated Burden of Disease in the United States
por: Ramirez, Julio, et al.
Publicado: (2023)

Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia
por: Sheikh, Daniya, et al.
Publicado: (2022)

Cardiovascular Complications Are the Primary Drivers of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Ali, Ahmed Shebl, et al.
Publicado: (2023)

In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza
por: Spindel, Jeffrey, et al.
Publicado: (2023)

Impact of Hyperglycemia on Cardiovascular Events and Clinical Outcomes in Patients Hospitalized With COVID-19 Pneumonia
por: Krishnasamy, Sathya, et al.
Publicado: (2022)

ODP633 Impact of Undiagnosed Diabetes on Cardiovascular Events and Clinical outcomes in Patients Hospitalized with COVID-19 Pneumonia
por: Krishnasamy, Sathya, et al.
Publicado: (2022)

Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Bradley, James, et al.
Publicado: (2022)

Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies
por: Ramirez, Julio A., et al.
Publicado: (2020)

812 Macrolide Use and Innate Immunity Components in Hospitalized Patients with Community-Acquired Pneumonia
por: Arnold, Forest W., et al.
Publicado: (2014)

Pneumococcal Vaccination in Immunocompromised Hosts: An Update
por: Froneman, Claire, et al.
Publicado: (2021)

Acute Respiratory Distress Syndrome and Time to Weaning Off the Invasive Mechanical Ventilator among Patients with COVID-19 Pneumonia
por: Bordon, Jose, et al.
Publicado: (2021)

2195. Incidence of Acute Myocardial Infarction in Patients with Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
por: Nieto Dominguez, Alejandro, et al.
Publicado: (2019)

In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia
por: Grijalva, Carlos G., et al.
Publicado: (2015)

Comparison of the clinical features of invasive pneumococcal disease with those of pneumococcal pneumonia in adults
por: Kuroki, Akane, et al.
Publicado: (2022)

Antimicrobial susceptibility of Streptococcus pneumoniae in adult patients with pneumococcal pneumonia in an urban hospital in Mozambique
por: Bos, Jeannet C, et al.
Publicado: (2014)

2171. Clinical Characteristics and Outcomes of Immunocompromised Patients with Enterococcal Pneumonia
por: Ajaka, Leama, et al.
Publicado: (2022)

Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients
por: Rouchka, Eric C., et al.
Publicado: (2021)

Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults
por: Isturiz, Raul, et al.
Publicado: (2021)

Incidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012
por: Contreras, Carmen Lucía, et al.
Publicado: (2015)

The severity and risk factors for mortality in immunocompromised adult patients hospitalized with influenza-related pneumonia
por: Chen, Liang, et al.
Publicado: (2021)

2205. Clinical Burden of Pneumococcal Disease in US Adults Aged 65 Years and Above with Chronic or Immunocompromising Conditions
por: Deb, Arijita, et al.
Publicado: (2019)

Simultaneous bilateral pneumothorax in an immunocompromised HIV patient with Pneumocystis jirovecii pneumonia
por: Matesanz López, Cristina, et al.
Publicado: (2018)

Pneumococcal pneumonia
por: Goldblatt, David, et al.
Publicado: (2020)

Clinical features and outcome of influenza pneumonia in critically-ill immunocompromised patients
por: Raymond, Matthieu, et al.
Publicado: (2022)

A Leukocyte Score to Improve Clinical Outcome Predictions in Bacteremic Pneumococcal Pneumonia in Adults
por: Blot, Mathieu, et al.
Publicado: (2014)

Association between body mass index and mortality in hospitalised patients with community-acquired pneumonia
por: Kim, Richard Y., et al.
Publicado: (2021)

Macrolide Resistance in Adults with Bacteremic Pneumococcal Pneumonia
por: Metlay, Joshua P., et al.
Publicado: (2006)

Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions
por: Liu, Junqing, et al.
Publicado: (2023)

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2017)

Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia
por: Egger, Michael E., et al.
Publicado: (2016)

Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study
por: Gaborit, Benjamin Jean, et al.
Publicado: (2019)

Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults
por: Isturiz, Raul, et al.
Publicado: (2015)

Clinical Features and Outcomes of Immunocompromised Adults Hospitalized with Laboratory-confirmed Influenza in the USA, 2011–2015
por: Collins, Jennifer, et al.
Publicado: (2017)

Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years
por: Schmidt, Julius J., et al.
Publicado: (2018)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
por: Fernández-Delgado, Lucía, et al.
Publicado: (2021)

Burden of Adults Hospitalized With Group B Streptococcal Infection
por: McLaughlin, John M, et al.
Publicado: (2020)

327. Comparison of Clinical Outcome, Causative Serotypes, and Antimicrobial Susceptibilities Between Pneumococcal Meningitis and Pneumococcal Bacteremic Pneumonia in Adult Patients in the Republic of Korea
por: Kim, Jeong Yeon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cmc3q8d7tfopf1a3sb1tlah44j